The Ohio-based Legal Examiner reviews the history of Johnson & Johnson’s allegedly inappropriate – perhaps criminal – marketing of Risperdal, including pushing the drug for off-label uses in children and the elderly.
J&J Allegedly Over-Promoted Risperdal and Paid the Price (Legal Examiner)